Petros Pharmaceuticals
NASDAQ: PTPI
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#47524
Market Cap
578,005
Volume
19.14 M
Price
0.27
Change (%)
10.00%
Country or region
United States
United States
Petros Pharmaceuticals Stock Split History Overview
This company has undergone a total of 2 stock splits throughout its history. 2 reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on May 1, 2025 with a ratio of 1-for-25. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Petros Pharmaceuticals (NASDAQ: PTPI) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| May 1, 2025 | 1:25 | x0.04 | x0.004 | Reverse |
| December 1, 2022 | 1:10 | x0.1 | x0.1 | Reverse |
Frequently Asked Questions
If Petros Pharmaceuticals (stock symbol: NASDAQ: PTPI) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-25) that occurred on May 1, 2025.
Petros Pharmaceuticals (stock symbol: NASDAQ: PTPI) has undergone a total of 2 stock splits. The most recent split occurred on May 1, 2025. One share bought prior to the first split on December 1, 2022 would now equal 0.00 shares.
Petros Pharmaceuticals (stock symbol: NASDAQ: PTPI) has undergone 2 stock splits in its history. The most recent split, a 1-for-10 split, occurred on May 1, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.